These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


95 related items for PubMed ID: 4080788

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Release of pyrazolone derivatives from suppositories formulated with hydrophilic and hydrophobic bases.
    Bećirević M, Petricić V.
    Pharmazie; 1986 May; 41(5):338-40. PubMed ID: 3737665
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biopharmaceutical studies of oral formulations containing propyphenazone.
    Shekerdjiiski R, Paskov V, Lambov N, Gencheva P, Rachev D, Titeva S, Minkov E.
    Pharmazie; 1987 Mar; 42(3):184-6. PubMed ID: 3602076
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The influence of method/apparatus conditions on the in vitro liberation of drugs from suppositories].
    Bornschein M.
    Pharmazie; 1986 Dec; 41(12):852-4. PubMed ID: 3575387
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [A comparative pharmacokinetic study for tablet and suppository formulations of a combination product of caffeine, ethaverine, propyphenazone, paracetamol and phenobarbital (author's transl)].
    Maier-Lenz H, Ringwelski L, Windorfer A.
    Arzneimittelforschung; 1981 Dec; 31(1):105-9. PubMed ID: 7194086
    [Abstract] [Full Text] [Related]

  • 11. Formulation and in vitro examination of furosemide containing suppositories and preliminary experiences of their clinical use.
    Regdon G, Fazekas T, Regdon G, Selmeczi B.
    Pharmazie; 1996 Feb; 51(2):116-9. PubMed ID: 8720807
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
    Minkov E, Lambov N, Kirchev D, Bantutova I, Tencheva J.
    Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
    [Abstract] [Full Text] [Related]

  • 14. [On various special physical properties and reciprocal action of suppositories prepared with witepsol-mass].
    Kata M.
    Pharmazie; 1968 Jul; 23(7):368-73. PubMed ID: 5700482
    [No Abstract] [Full Text] [Related]

  • 15. In vitro methods for the evaluation of drug availability from suppositories: comparison between biological and artificial membranes.
    Realdon N, Ragazzi E, Morpurgo M, Ragazzi E.
    Pharmazie; 2005 Oct; 60(10):756-60. PubMed ID: 16259123
    [Abstract] [Full Text] [Related]

  • 16. [Effect of the degree of dispersion on drug release from aminophenazone suppositories in vitro].
    Kata M, Kedvessy G.
    Pharmazie; 1968 Nov; 23(11):667-8. PubMed ID: 5721357
    [No Abstract] [Full Text] [Related]

  • 17. [The dynamics of drug release from suppositories. Part 6: The effects of lipophil and hydrophilic suppository bases on the release of adeiphenin (author's transl)].
    Pasich J, Brobnicka B, Kasprzyk A.
    Pharmazie; 1980 Nov; 35(7):416-7. PubMed ID: 6106209
    [Abstract] [Full Text] [Related]

  • 18. [Blood and urine concentrations following intake of propyphenazone].
    Moosmayer A, Besserer K.
    Beitr Gerichtl Med; 1982 Nov; 40():335-9. PubMed ID: 7165655
    [No Abstract] [Full Text] [Related]

  • 19. Biopharmaceutical studies on hydantoin derivatives. III. Physico-chemical properties, dissolution behavior, and bioavailability of the molecular compound of 1-benzenesulfonyl-5,5-diphenylhydantoin and antipyrine.
    Fujioka H, Tan T.
    J Pharmacobiodyn; 1982 Jul; 5(7):475-84. PubMed ID: 6982326
    [Abstract] [Full Text] [Related]

  • 20. The study of the bioavailability of coated acetylsalicylic acid in suppositories after rectal administration.
    Stozek T.
    Pol J Pharmacol Pharm; 1975 Jul; 27(2):227-33. PubMed ID: 1153355
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.